id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3758-0015,FDA,FDA-2018-N-3758,Individual Patient Expanded Access Investigational New Drug Application (IND),Other,Forms,2022-11-10T05:00:00Z,2022,11,2022-11-10T05:00:00Z,,2022-11-10T20:24:32Z,,0,0,09000064854a3f42
FDA-2018-N-3758-0014,FDA,FDA-2018-N-3758,"INSTRUCTIONS FOR FILLING OUT FORM FDA 3926 – INDIVIDUAL PATIENT EXPANDED
ACCESS, INVESTIGATIONAL NEW DRUG APPLICATION (IND)",Other,Forms,2022-11-10T05:00:00Z,2022,11,2022-11-10T05:00:00Z,,2022-11-10T20:23:16Z,,0,0,09000064854a4474
FDA-2018-N-3758-0013,FDA,FDA-2018-N-3758,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2022-07-06T04:00:00Z,2022,7,2022-07-06T04:00:00Z,,2023-04-27T14:50:33Z,2022-14348,0,0,09000064851b2f1d
FDA-2018-N-3758-0011,FDA,FDA-2018-N-3758,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Expanded Access to Investigational Drugs for Treatment Use,Notice,30 Day Proposed Information Collection,2022-04-28T04:00:00Z,2022,4,2022-04-28T04:00:00Z,2022-06-01T03:59:59Z,2023-04-27T14:50:20Z,2022-09070,0,0,090000648503dd7f